Dataset Information


Comprehensive analysis of gene expression and DNA methylation data identifies potential biomarkers and functional epigenetic modules for lung adenocarcinoma.

ABSTRACT: Lung cancer has one of the highest mortality rates of malignant neoplasms. Lung adenocarcinoma (LUAD) is one of the most common types of lung cancer. DNA methylation is more stable than gene expression and could be used as a biomarker for early tumor diagnosis. This study is aimed to screen potential DNA methylation signatures to facilitate the diagnosis and prognosis of LUAD and integrate gene expression and DNA methylation data of LUAD to identify functional epigenetic modules. We systematically integrated gene expression and DNA methylation data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO), bioinformatic models and algorithms were implemented to identify signatures and functional modules for LUAD. Three promising diagnostic and five potential prognostic signatures for LUAD were screened by rigorous filtration, and our tumor-normal classifier and prognostic model were validated in two separate data sets. Additionally, we identified functional epigenetic modules in the TCGA LUAD dataset and GEO independent validation data set. Interestingly, the MUC1 module was identified in both datasets. The potential biomarkers for the diagnosis and prognosis of LUAD are expected to be further verified in clinical practice to aid in the diagnosis and treatment of LUAD.


PROVIDER: S-EPMC7299274 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7339160 | BioStudies
2021-01-01 | S-EPMC7894106 | BioStudies
2020-01-01 | S-EPMC7368195 | BioStudies
2019-01-01 | S-EPMC6497041 | BioStudies
2020-01-01 | S-EPMC7427766 | BioStudies
2016-01-01 | S-EPMC5342499 | BioStudies
2020-01-01 | S-EPMC7648248 | BioStudies
2019-01-01 | S-EPMC6492637 | BioStudies
2020-01-01 | S-EPMC7396235 | BioStudies
2020-01-01 | S-EPMC7192063 | BioStudies